Acad, Gov/Utilities Archives - Page 24 of 53

QIAGEN and DiaSorin receive FDA approval for the LIAISON QuantiFERON-TB Gold Plus Test on LIAISON platforms and begin commercial launch

Germantown, Maryland; Hilden, Germany; and Saluggia, Italy, November 27, 2019 –QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the U.S. launch of an automated workflow for QuantiFERON-TB Plus (QFT-Plus), the fourth-generation modern gold standard for latent tuberculosis (TB) detection, on DiaSorin’s LIAISON platforms. The U.S. Food and Drug Administration... Read more

November 25, 2019 Acad, Gov/Utilities

MTS Expands Presence in Wind Energy and Aerospace Markets Through Acquisition of Danish Engineering Firm

EDEN PRAIRIE, Minn. , Nov. 25, 2019 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of high-performance test and simulation systems and sensors, announced today that, on November 22, 2019 , it signed a definitive agreement to acquire the operating entities of R&D, Read more

November 18, 2019 Acad, Gov/Utilities

GE Healthcare Announces the First U.S. FDA 510(k) Cleared Deep Learning Based CT Image Reconstruction Technology

WAUKESHA, Wis., April 18, 2019 – GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration of its Deep Learning Image Reconstruction engine on its new Revolution Apex CT device and as an upgrade to its Revolution CT system in the United States. “We are proud to usher in the next generation... Read more

November 15, 2019 Acad, Gov/Utilities Environ, Ag./Food & Bev Lab Top-10

Danaher Will Commence Exchange Offer Related To Divestiture Of Its Remaining Interest In Envista Through A Split-Off

Danaher Will Commence Exchange Offer Related To Divestiture Of Its Remaining Interest In Envista Through A Split-Off WASHINGTON, Nov. 15, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will commence an exchange offer related to the split-off of its remaining interest in Envista Holdings Corporation (NYSE: NVST). Envista completed its initial public offering... Read more

November 14, 2019 Acad, Gov/Utilities Clinical Research/Diagn.

Clinical Radiological Technologist Training and Education Facility Established at a University in the United States (MSU)‒ The first Corporate Sponsored Radiologic Science Program in the United States ‒

Clinical Radiological Technologist Training and Education Facility Established at a University in the United States (MSU) ‒ The first Corporate Sponsored Radiologic Science Program in the United States ‒ Read more

November 14, 2019 Acad, Gov/Utilities Clinical Research/Diagn.

Clinical Radiological Technologist Training and Education Facility Established at a University in the United States (MSU)‒ The first Corporate Sponsored Radiologic Science Program in the United States ‒

November 7, 2019 Acad, Gov/Utilities Mass Spectrometry

World’s First Cyclic IMS Mass Spectrometer Installed at Aston University

Technology brings university scientists unparalleled potential for chemical, biological and human disease research First commercial research instrument of its kind in the world. MILFORD, Mass.–(BUSINESS WIRE)–Nov. 7, 2019– Aston University and Waters Corporation (NYSE: WAT) announced today the completed installation of the world’s first Waters™ SELECT SERIES™ Cyclic™ IMS (ion mobility spectrometry) mass spectrometer within the University’s School of Health and Life... Read more

November 6, 2019 Acad, Gov/Utilities Licensing, IP, and Legal PAI Top-10 Product Launch

Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting

Basel, 06 November 2019 Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting Ten Roche medicines will be featured in more than 70 abstracts and 21 oral presentations, across a range of 15 blood cancers and non-malignant haematological conditions New data for CD20-CD3... Read more

November 4, 2019 Acad, Gov/Utilities Lab Top-10 PAI Top-10 PR/Corporate

Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA

AUSTIN, Texas, Nov. 4, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). Comparisons shown in this release are to the same period in the prior year unless otherwise noted. CURRENT... Read more

November 4, 2019 Acad, Gov/Utilities Bio/Pharma/CRO

GE Healthcare announces U.S. FDA approval of macrocyclic MRI contrast agent Clariscan™ (gadoterate meglumine) injection for intravenous use

Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products Chalfont St Giles, UK – November 4 2019 – The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast... Read more